Accelerating Innovation in Primary Care to Support Adolescent Health Discussions.

Background And Objectives: Adolescent strengths and risks are not routinely captured in systematized and actionable ways in pediatric primary care. To address this problem, we developed a comprehensive adolescent health questionnaire (AHQ) integrated within the electronic health record and evaluated the AHQ's impact on collection of information on prioritized health-related domains.

Methods: We developed and pilot tested the AHQ.

Should you get a booster?

As the UK and US embark on large-scale coronavirus vaccine booster campaigns, considers the evidence on whether you should get another shot.

What doesn't kill you… ?

The odd sniffle was nothing to worry about until covid-19 burst our bubble. It is time we paid more attention to minor ailments, says .

UK covid-19 cases fall.

Coronavirus infections have fallen for seven days in a row, but whether it is a genuine drop remains to be seen, reports .

How do we live with covid-19?

The UK government has said it is now time to "learn to live with covid". Here's what that looks like, write , , and .

It isn't too late to eliminate.

Countries opting to eliminate covid-19 rather than reduce its spread have fared best - and there's still time to adopt the strategy, reports .

Did covid-19 come from a lab?

Could the coronavirus have sprung from a lab or did it pass to humans from an animal? The evidence is out there, but it could be difficult to locate, says .

Caution needed in the UK.

Has lockdown been eased too soon in the UK considering the surge in cases of a coronavirus variant from India? reports.

Are booster shots coming?

Vaccine top-ups might boost immune systems and block new coronavirus variants, but there are many unknowns, reports .

Sputnik V vaccine goes global.

Non-Western vaccines are serious players in the global effort against covid-19, but we need more transparent data, reports .

US won't delay second dose.

Countries disagree on coronavirus vaccination strategies amid warnings that a long time between shots could create lethal variants, says .

Sights set on universal vaccine.

Scientists have begun the race to create a single vaccine that protects us from all future coronaviruses, with human trials starting soon, finds .

The coronavirus evolves.

Several new viral variants pose added threats - how worried should we be?

When will life return to normal?

We start the new year with effective coronavirus vaccines, but the end of the pandemic is still a way off. So what will life be like in 2021, as we glimpse the beginning of the end of the crisis, ask , , , and .

How we got to know a new enemy.

In an extraordinary year for science, research into covid-19 has shed a bright light on the unknown, reports .

Will vaccine immunity last?

The latest results offer cautious optimism that vaccines will give us the kind of immunity we need to end the pandemic, reports .

Your guide to the new vaccine.

The UK has taken delivery of the first doses of a coronavirus vaccine. How does it work and who will get it when? reports.

Trial results come under fire.

Doubts have been raised over some aspects of the test of AstraZeneca and the University of Oxford's covid-19 vaccine. reports.

Vaccines: hope vs reality.

Are the candidate vaccines in late-stage human trials really everything the world has been waiting for, asks .

Mink could be just the start.

The fact that the coronavirus can spread back and forth between humans and animals is bad news for all involved, reports .

How exciting is the Pfizer vaccine?

The company says its vaccine is 90 per cent effective. What does this really mean and what do we still need to know? reports.

The stopgap before a vaccine.

Antibodies in the blood of people who have had covid-19 could be just what we need to tide us over until we have a vaccine, reports .

The great viral team-up.

Viruses are no lone wolves. They have social lives and work together in ways we ignore at our peril, finds Graham Lawton.

The evolving coronavirus.

The coronavirus has mutated very little, but as more people are treated or vaccinated it could face pressure to evolve, finds .